These international patent data are derived from patent families, based on US drug-patent linkages.
They should not be regarded as comprehensive records of ex-US drug-patent associations.
|Country||Document Number||Supplementary Protection Certificate||SPC Country||SPC Description||SPC Expiration|
|European Patent Office||0208846||99C0032||Belgium||PRODUCT NAME: ZANAMIVIR; NAT. REGISTRATION NO/DATE: NL 24 551 19990726; FIRST REGISTRATION: SE - 14 997 19990209||► subscribe|